inotuzumab as a potential treatment for elderly patients with all
Published 6 years ago • 140 plays • Length 3:28Download video MP4
Download video MP3
Similar videos
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
3:29
is inotuzumab ozogamicin with low-dose chemotherapy effective in treating all in elderly patients?
-
1:46
inotuzumab-containing bridging therapy in patients with r/r b-all receiving obe-cel
-
2:37
the addition of inotuzumab ozogamicin to hyper-cvad blinatumomab in patients with b-all
-
1:09
the future of inotuzumab therapy for all
-
2:13
elderly all advances: inotuzumab ozogamicin plus mini-hyper-cvd
-
4:44
emerging novel approaches for all: inotuzumab ozogamicin
-
4:26
making an impact in all therapy: how can cure rates be improved?
-
3:04
immunotherapy for frontline treatment of all: inotuzumab ozogamicin and blinatumomab
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
2:09
advances in the management of fit adults with aml
-
3:03
novel all treatment strategies: inotuzumab ozogamicin
-
1:33
sorafenib as maintenance therapy for patients with transplant-ineligible or post-allosct aml
-
2:19
addition of inotuzumab to allosct conditioning regimen in relapsed cd22 ( ) lymphoid malignancies
-
2:17
choosing between inotuzumab ozogamicin and blinatumomab in patients with r/r all
-
1:55
treatment of intermediate-risk aml with gemtuzumab ozogamicin
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl
-
2:12
results from phase i study of alnuctamab administered intravenously & subcutaneously in r/r myeloma